Early Detection

Alzheimer’s Disease Diagnostic

Diagnosis and treatment of Alzheimer’s disease is evolving rapidly. As treatment options expand, we believe that early detection is the key to allowing for meaningful therapeutic intervention.

Our easy-to-administer, blood-based diagnostic for Alzheimer’s disease monitors multiple blood proteins for earlier, more accurate detection.

We are currently conducting pre-validation studies and expect to begin validation studies for our Alzheimer’s diagnostic in 2011.